Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Microb Drug Resist ; 26(5): 468-474, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31755808

RESUMEN

The aim of this study was to assess the efficacy of benzyl isothiocyanate (BITC) in combination with efflux inhibitors and metal chelators against multidrug-resistant Escherichia coli. In vitro synergism between testing molecules was observed based on the minimal inhibitory concentration (MIC), minimal bactericidal concentration (MBC), fractional inhibitory concentration index (FICI), bactericidal kinetics, and growth inhibition assay. BITC alone exhibited moderate antibacterial activity against E. coli strains with MIC and MBC values of 0.625-1.25 µM and 1.25-2.5 µM, respectively. In contrast, double and triple combinations of BITC, ethylenediaminetetraacetic acid (EDTA), and phenylalanine-arginine ß-naphthylamide (PAßN) resulted in synergistic activities with FICI values between 0.18 and 0.5, whereas combination of BITC with carbonyl cyanide m-chlorophenyl hydrazone or 2, 2'-dipyridyl revealed additive or indifference effect with FICI values of 0.75-1.5 and 1-1.5, respectively. Results of bactericidal kinetics and growth inhibition assays also supported the synergistic effects of EDTA and PAßN with BITC against E. coli strains. Our data demonstrate the possible use of adjuvant agents, such as the chelating agent EDTA and the efflux inhibitor PAßN to improve the antibacterial potential of isothiocyanate and may help to develop an alternative strategy for reducing the occurrence of multidrug resistance.


Asunto(s)
Antibacterianos/farmacología , Dipéptidos/farmacología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Ácido Edético/farmacología , Escherichia coli/efectos de los fármacos , Isotiocianatos/farmacología , Técnicas Bacteriológicas , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Sinergismo Farmacológico , Proteínas de Escherichia coli/efectos de los fármacos
2.
Int J Mol Sci ; 13(2): 2459-2471, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22408464

RESUMEN

Circular dichroism (CD) and deconvolution were used to study the structural integrity of a "plugged" and an "open" FhuA transmembrane channel protein in the presence of varied concentrations of tetrahydrofuran (THF), ethanol (EtOH) and chloroform/methanol (C/M). FhuA is an Escherichia coli outer membrane protein (78.9 kDa) consisting of 22 ß-sheets and an internal globular cork domain which acts as an iron transporter. FhuA and the deletion variant FhuA Δ1-159 showed comparable and remarkable resistance in the presence of THF (≤40 vol%) and EtOH (≤10 vol%). In C/M, significant differences in structural resistance were observed (FhuA stable ≤10 vol%; FhuA Δ1-159 ≤1 vol%). Deconvolution of CD-spectra for FhuA and FhuA Δ1-159 yielded ß-sheet contents of 61 % (FhuA) and 58% (FhuA Δ1-159). Interestingly, FhuA and FhuA Δ1-159 had comparable ß-sheet contents in the presence and absence of all three organic cosolvents. Additionally, precipitated FhuA and FhuA Δ1-159 (in 40 vol% C/M or 65 vol% THF) redissolved by supplementing the detergent n-octyl-oligo-oxyethylene (oPOE).


Asunto(s)
Proteínas de la Membrana Bacteriana Externa/efectos de los fármacos , Proteínas de Escherichia coli/efectos de los fármacos , Compuestos Orgánicos/farmacología , Solventes/farmacología , Proteínas de la Membrana Bacteriana Externa/química , Proteínas de la Membrana Bacteriana Externa/genética , Cloroformo/farmacología , Dicroismo Circular , Escherichia coli , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/genética , Etanol/farmacología , Furanos/farmacología , Eliminación de Gen , Metanol/farmacología , Proteínas Mutantes/química , Proteínas Mutantes/efectos de los fármacos , Estructura Secundaria de Proteína/efectos de los fármacos , Estructura Terciaria de Proteína/efectos de los fármacos
3.
Vopr Pitan ; 75(4): 23-8, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-17089565

RESUMEN

Modified and resistant starches regulate the colon microbiota metabolism and gene expression. This adaptive response allows bacteria to obtain the new enzymes to metabolize the unusual substrates. The potato starches modify the colon residential microorganisms. It was a reason the study the influence of the modified and resistant potato starches on the E. coli lines defected in the gene reparation system. It allows us to estimate the participation of some components of gene reparation system in the adoptive response of bacteria to the chemical compounds. Potato starches in the concentration 1% have been found to be indifferent to the DNA E. coli lines Wp. RecA. PolA [Russian character: see text] UvrA. High amilose notato starch stimulates these lines growth that indicates to its prebiotic canacities.


Asunto(s)
Escherichia coli/efectos de los fármacos , Solanum tuberosum/química , Almidón/química , Almidón/farmacología , Adenosina Trifosfatasas/genética , Reparación del ADN/efectos de los fármacos , Reparación del ADN/genética , Proteínas de Unión al ADN/genética , Relación Dosis-Respuesta a Droga , Escherichia coli/genética , Proteínas de Escherichia coli/efectos de los fármacos , Proteínas de Escherichia coli/genética , Rec A Recombinasas/genética
4.
J Biomol Screen ; 9(4): 303-8, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15191647

RESUMEN

The increasing number of multiantibiotic-resistant organisms, including methicillin-resistant Staphylococcus aureus (MRSA), requires the development of novel chemotherapies that are structurally distinct and exempt from current resistance mechanisms. Bioinformatics data mining of microbial genomes has revealed numerous previously unexploited essential open reading frames (ORFs) of unknown biochemical function. The potential of these proteins as screening targets is not readily apparent because most screening technologies rely on knowledge of biological function. To address this problem, the authors employed affinity capillary electrophoresis (ACE) to identify antimicrobial compounds that bound the novel target YihA. Screening a small-molecule library of 44,000 compounds initially identified 115 binders, of which 76% were confirmed. Furthermore, the ACE assay distinguished diverse compounds that possessed drug-like properties and antimicrobial activity against drug-resistant clinical isolates. These data validate ACE as a valuable tool for the fast, efficient detection of specific binding molecules that possess biological activity.


Asunto(s)
Antibacterianos/farmacología , Evaluación Preclínica de Medicamentos/métodos , Electroforesis Capilar/métodos , Secuencia de Bases , ADN Bacteriano/genética , Farmacorresistencia Bacteriana/genética , Proteínas de Escherichia coli/efectos de los fármacos , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Proteínas de Unión al GTP/efectos de los fármacos , Proteínas de Unión al GTP/genética , Proteínas de Unión al GTP/metabolismo , Ligandos , Resistencia a la Meticilina/genética , Unión Proteica , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA